These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5665241)

  • 1. The action of arabinosylcytosine on synchronously growing populations of mammalian cells.
    Young RS; Fischer GA
    Biochem Biophys Res Commun; 1968 Jul; 32(1):23-9. PubMed ID: 5665241
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of 1-beta-D-arabinofuranosylcytosine in L cells.
    Silagi S
    Cancer Res; 1965 Oct; 25(9):1446-53. PubMed ID: 5861073
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell morphology of a human diploid cell strain (WI-38) after treatment with arabinosylcytosine.
    Heneen WK; Nichols WW
    Cancer Res; 1967 Feb; 27(2):242-50. PubMed ID: 6018558
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of-beta-D-arabinofuranosylcytosine on growth, viability, and DNA synthesis of mouse L-cells.
    Graham FL; Whitmore GF
    Cancer Res; 1970 Nov; 30(11):2627-35. PubMed ID: 5530557
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the induction of chromosomal aberrations in human leukocytes by cytosine arabinoside.
    Brewen JG; Christie NT
    Exp Cell Res; 1967 May; 46(2):276-91. PubMed ID: 6028140
    [No Abstract]   [Full Text] [Related]  

  • 6. Deoxynucleoside inhibition of differentiation in cultured embryonic cells.
    Landström U; Lovtrup S
    Exp Cell Res; 1977 Aug; 108(1):201-6. PubMed ID: 891629
    [No Abstract]   [Full Text] [Related]  

  • 7. Chromosomal effects of arabinosylcytosine in a human diploid cell strain.
    Nichols WW; Heneen WK
    Hereditas; 1965; 52(3):402-10. PubMed ID: 5828748
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival responses of dividing and nondividing mammalian cells after treatment with hydroxyurea, arabinosylcytosine, or adriamycin.
    Barranco SC; Novak JK
    Cancer Res; 1974 Jul; 34(7):1616-8. PubMed ID: 4858112
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of chemically induced and virus-induced chromosome aberrations.
    Nichols WW
    Fed Proc; 1969; 28(6):1794-6. PubMed ID: 4311074
    [No Abstract]   [Full Text] [Related]  

  • 10. DNA synthesis during the life cycle of L cells: morphological, histochemical and biochemical investigations with arabinosylcytosine and thioarabinosylcytosine.
    Bremerskov V; Kaden P; Mittermayer C
    Eur J Cancer (1965); 1970 Oct; 6(5):379-92. PubMed ID: 5500706
    [No Abstract]   [Full Text] [Related]  

  • 11. Action of 1-beta-D-arabinofuranosyl-5-fluorocytosine on the nucleic acid metabolism and viability of HeLa cells.
    Kim JH; Eidinoff ML; Fox JJ
    Cancer Res; 1966 Aug; 26(8):1661-4. PubMed ID: 5923164
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential sensitivites of human melanoma cells grown in vitro to arabinosylcytosine.
    Barranco SC; Ho DH; Drewinko B; Romsdahl MM; Humphrey RM
    Cancer Res; 1972 Dec; 32(12):2733-6. PubMed ID: 4644205
    [No Abstract]   [Full Text] [Related]  

  • 13. Biochemical and genetic studies of a mutant strain of mouse leukemia L1210 resistant to 1-beta-D-arabinofuranosylcytosine (Cytarabine).
    Bach MK
    Cancer Res; 1969 May; 29(5):1036-44. PubMed ID: 5781095
    [No Abstract]   [Full Text] [Related]  

  • 14. Nuclear changes in Friend erythroleukemia cells treated with arabinosylcytosine in vitro.
    Conforti A; Fragomele F; Modesti A; Lazzaro D
    Int J Tissue React; 1984; 6(2):111-21. PubMed ID: 6588045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of antimetabolites on kinetic behavior of proliferating cultured L1210 leukemia cells.
    Wilkoff LJ; Wilcox WS; Burdeshaw JA; Dixon GJ; Dulmadge EA
    J Natl Cancer Inst; 1967 Nov; 39(5):965-75. PubMed ID: 6071005
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences between diploid and heteroploid cultured mammalian cells in their response to puromycin aminonucleoside.
    Studzinski GP; Ellem KA
    Cancer Res; 1968 Sep; 28(9):1773-82. PubMed ID: 5676734
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds.
    Renis HE
    Cancer Res; 1970 Jan; 30(1):189-94. PubMed ID: 5466741
    [No Abstract]   [Full Text] [Related]  

  • 18. Puromycin-induced necrosis of crypt cells of the small intestine of mouse.
    Estensen RD; Baserga R
    J Cell Biol; 1966 Jul; 30(1):13-22. PubMed ID: 5966172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.
    Skipper HE; Schabel FM; Wilcox WS
    Cancer Chemother Rep; 1967 Jun; 51(3):125-65. PubMed ID: 6043735
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between RNA synthesis, cell division, and morphology of mammalian cells. I. Puromycin aminonucleoside as an inhibitor of RNA synthesis and division in HeLa cells.
    Studzinski GP; Ellem KA
    J Cell Biol; 1966 Jun; 29(3):411-21. PubMed ID: 5962936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.